BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Das UN. Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? Front Endocrinol (Lausanne) 2017;8:182. [PMID: 28824543 DOI: 10.3389/fendo.2017.00182] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther 2021;6:94. [PMID: 33637672 DOI: 10.1038/s41392-020-00443-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
2 Gundala NK, Naidu VG, Das UN. Amelioration of streptozotocin-induced type 2 diabetes mellitus in Wistar rats by arachidonic acid. Biochemical and Biophysical Research Communications 2018;496:105-13. [DOI: 10.1016/j.bbrc.2018.01.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
3 Abot A, Wemelle E, Laurens C, Paquot A, Pomie N, Carper D, Bessac A, Mas Orea X, Fremez C, Fontanie M, Lucas A, Lesage J, Everard A, Meunier E, Dietrich G, Muccioli GG, Moro C, Cani PD, Knauf C. Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice. Gut 2021;70:1078-87. [PMID: 33020209 DOI: 10.1136/gutjnl-2019-320230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
4 Purdel C, Ungurianu A, Margina D. Metabolic and Metabolomic Insights Regarding the Omega-3 PUFAs Intake in Type 1 Diabetes Mellitus. Front Mol Biosci 2021;8:783065. [PMID: 34926582 DOI: 10.3389/fmolb.2021.783065] [Reference Citation Analysis]
5 Das UN. Bioactive lipids as modulators of immune check point inhibitors. Med Hypotheses 2020;135:109473. [PMID: 31733534 DOI: 10.1016/j.mehy.2019.109473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Gu D, Ding Y, Zhao Y, Miao S, Qu Q. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome. Lipids Health Dis 2018;17:101. [PMID: 29734946 DOI: 10.1186/s12944-018-0761-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I. Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases. Int J Mol Sci 2018;19:E3285. [PMID: 30360467 DOI: 10.3390/ijms19113285] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 19.5] [Reference Citation Analysis]
8 Hancock WD, Lei X, Clines GA, Tusing YG, Nozell SE, Ramanadham S. Ca2+-independent phospholipase A2β-derived PGE2 contributes to osteogenesis. Prostaglandins Other Lipid Mediat 2021;158:106605. [PMID: 34923151 DOI: 10.1016/j.prostaglandins.2021.106605] [Reference Citation Analysis]
9 Chu CS, Law SH, Lenzen D, Tan YH, Weng SF, Ito E, Wu JC, Chen CH, Chan HC, Ke LY. Clinical Significance of Electronegative Low-Density Lipoprotein Cholesterol in Atherothrombosis. Biomedicines 2020;8:E254. [PMID: 32751498 DOI: 10.3390/biomedicines8080254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Song J, Sun R, Zhang Y, Fu Y, Zhao D. Role of the Specialized Pro-resolving Mediator Resolvin D1 in Hashimoto's Thyroiditis. Exp Clin Endocrinol Diabetes 2021;129:791-7. [PMID: 33465800 DOI: 10.1055/a-1345-0173] [Reference Citation Analysis]
11 Bonyek-Silva I, Machado AFA, Cerqueira-Silva T, Nunes S, Silva Cruz MR, Silva J, Santos RL, Barral A, Oliveira PRS, Khouri R, Serezani CH, Brodskyn C, Caldas JR, Barral-Netto M, Boaventura V, Tavares NM. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes. Diabetes 2021;70:2120-30. [PMID: 34417262 DOI: 10.2337/db20-1260] [Reference Citation Analysis]
12 Aryal P, Syed I, Lee J, Patel R, Nelson AT, Siegel D, Saghatelian A, Kahn BB. Distinct biological activities of isomers from several families of branched fatty acid esters of hydroxy fatty acids (FAHFAs). J Lipid Res 2021;62:100108. [PMID: 34418413 DOI: 10.1016/j.jlr.2021.100108] [Reference Citation Analysis]
13 Liu G, Bei J, Liang L, Yu G, Li L, Li Q. Stachyose Improves Inflammation through Modulating Gut Microbiota of High-Fat Diet/Streptozotocin-Induced Type 2 Diabetes in Rats. Mol Nutr Food Res. 2018;62:e1700954. [PMID: 29341443 DOI: 10.1002/mnfr.201700954] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
14 Tallima H, El Ridi R. Arachidonic acid: Physiological roles and potential health benefits - A review. J Adv Res 2018;11:33-41. [PMID: 30034874 DOI: 10.1016/j.jare.2017.11.004] [Cited by in Crossref: 141] [Cited by in F6Publishing: 114] [Article Influence: 28.2] [Reference Citation Analysis]
15 Das UN. Bioactive Lipids in Age-Related Disorders. Adv Exp Med Biol 2020;1260:33-83. [PMID: 32304030 DOI: 10.1007/978-3-030-42667-5_3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wan M, Ding L, Wang D, Han J, Gao P. Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases. Front Immunol 2020;11:186. [PMID: 32117308 DOI: 10.3389/fimmu.2020.00186] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
17 Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases. Cells 2019;8:E1573. [PMID: 31817238 DOI: 10.3390/cells8121573] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
18 Das UN. Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review. J Adv Res 2019;17:17-29. [PMID: 31193303 DOI: 10.1016/j.jare.2018.12.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
19 Das UN. Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review. J Adv Res 2018;11:43-55. [PMID: 30034875 DOI: 10.1016/j.jare.2018.01.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
20 Ježek P, Jabůrek M, Holendová B, Plecitá-Hlavatá L. Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity. Molecules 2018;23:E1483. [PMID: 29921789 DOI: 10.3390/molecules23061483] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
21 Wasserman AH, Venkatesan M, Aguirre A. Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration. Cells 2020;9:E1391. [PMID: 32503253 DOI: 10.3390/cells9061391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Bathina S, Gundala NKV, Rhenghachar P, Polavarapu S, Hari AD, Sadananda M, Das UN. Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain. Arch Med Res 2020;51:492-503. [PMID: 32451116 DOI: 10.1016/j.arcmed.2020.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
23 García-Marchena N, Pizarro N, Pavón FJ, Martínez-Huélamo M, Flores-López M, Requena-Ocaña N, Araos P, Silva-Peña D, Suárez J, Santín LJ, de la Torre R, Rodríguez de Fonseca F, Serrano A. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients. Sci Rep 2020;10:17163. [PMID: 33051508 DOI: 10.1038/s41598-020-74155-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]